NERV compared with FBRX: revenue, margins and what each company keeps, and the suppliers and customers both name

NERVMinerva Neurosciences, Inc.

Mkt capRevenueRevenue

FBRXForte Biosciences, Inc.

Mkt capRevenueRevenue

Compare

NERVMinerva Neurosciences, Inc.

FBRXForte Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only NERV 7

RPRXRoyalty Pharma plc ("Royalty Pharma")customer

—Catalentunlistedsupplier

—Catalent Germany Schorndorf GmbHunlistedsupplier

—Dr. Inderjit Kaulunlistedsupplier

3 more · NERV chain ›

Shared 0

No disclosed counterparties: FBRX.

Only FBRX 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

NERVMinerva Neurosciences, Inc.

2.40▲+4.42%· post 2.25

Mkt cap$120.6M

FBRXForte Biosciences, Inc.

76.99▲+0.03%· post 77.01

ClosedNov 6 '26

Mkt cap$1.6B

Compare

ClosedNov 6 '26

NERVMinerva Neurosciences, Inc.

FBRXForte Biosciences, Inc.

2.40▲+4.42%post 2.25

Price

76.99▲+0.03%post 77.01

$120.6M

Mkt cap

$1.6B

NERV2.40▲+4.42%vsFBRX76.99▲+0.03%ClosedNov 6 '26